Balanced crystalloids versus normal saline for fluid resuscitation in critically ill patients: A systematic review and meta-analysis with trial sequential analysis

Abstract

a b s t r a c tIntroduction: Fluid resuscitation is a fundamental component of the management of critically ill patients, but whether choice of crystalloid affects patient outcomes remains controversial. Therefore, we performed this meta-analysis to compare the efficacy and safety of balanced crystalloids with normal saline. Methods: We searched the MEDLINE, Cochrane Central and EMBASE up to October 2018 to identify randomized controlled trials (RCTs) that compared balanced crystalloids versus normal saline in critically ill patients. The primary outcome was mortality. The secondary results were the incidence of acute kidney injury (AKI) and risk of receiving renal replacement therapy (RRT). Two authors independently screened articles based on the inclusion and exclusion criteria. The meta-analysis was conducted using Revman 5.3, trial sequential analysis (TSA) 0.9 and STATA 12.0. Results: Nine RCTs were identified. The pooled analyses showed that there were no significant differences in mortality (relative risk (RR) = 0.93, 95% confidence interval (CI) = 0.86, 1.01, P = 0.08), incidence of AKI (RR 0.94, 95% CI 0.88, 1.00, P = 0.06) or RRT use rate (RR 0.94, 95% CI 0.69, 1.27, P = 0.67) between balanced crystalloids and normal saline groups. However, TSA did not provide conclusive evidence. Conclusions: Among critically ill patients receiving crystalloid fluid therapy, use of a balanced crystalloid compared with normal saline did not reduce the mortality, risk of severe AKI or RRT use rate. Further large randomized clinical trials are needed to confirm or refute this finding. Trial registration: A protocol of this meta-analysis has been registered on PROSPERO (registration number: CRD42018094857).

Safety and Efficacy of Roxadustat for Anemia in Patients With Chronic Kidney Disease: A Meta-Analysis and Trial Sequential Analysis

“…The type I error (α) = 0.05 (two-sided) and power (1 – β) = 0.80. The control event proportion was calculated from the comparator group ( 23 ). The TSA was conducted using TSA Version 0.9.5.10 Beta ( www.ctu.dk/tsa ).…”

Efficacy and safety of finerenone in patients with chronic kidney disease: a systematic review with meta-analysis and trial sequential analysis

“…We used a power (1-β) of 0.90 to calculate the required information size for all the results. The control event proportion was calculated based on the comparator group (24). The TSA was conducted using TSA Version 0.9.5.10 Beta (www.ctu.dk/tsa).…”

Urgent need for a randomized controlled trial with only septic patients!

“…While the authors found no significant difference in survival, the severity of acute kidney injury (AKI), and the need for renal replacement therapy (RRT), which they noted in septic patients with hyperchloremic acidosis,the use of normal saline was associated with increased mortality [1]. These findings have also been previously reported [2]. High chloride level in the macula densa would activate the glomerulo-tubular feedback causing vasoconstriction of the afferent arteriole.…”